Marc Blatchford
About Marc Blatchford
Marc Blatchford is a Director at Erasca, Inc. in San Diego, CA, where he has worked since 2021. He has extensive experience in the pharmaceutical industry, having held various scientific and leadership roles at companies such as Gilead Sciences, Novartis Pharmaceuticals, and Ardelyx, Inc.
Work at Erasca
Marc Blatchford has served as Director at Erasca, Inc. since 2021. His role involves overseeing various projects and initiatives within the company, which is based in San Diego, CA. His tenure at Erasca spans three years, during which he has contributed to the company's focus on developing innovative cancer therapies.
Previous Experience in Biopharmaceuticals
Before joining Erasca, Marc Blatchford held several significant positions in the biopharmaceutical industry. He worked as Research Scientist II at Gilead Sciences from 2012 to 2016. Prior to that, he was an Associate Principal Scientist at Schering-Plough from 2005 to 2009 and a Principal Scientist at Novartis Pharmaceuticals from 2009 to 2012. He also served as Associate Director at Ardelyx, Inc. from 2018 to 2021 and as Senior Scientist at Achaogen from 2016 to 2018.
Education and Expertise
Marc Blatchford earned his Ph.D. in Analytical Chemistry from the University of North Carolina at Chapel Hill, where he studied from 1998 to 2003. He also holds a Bachelor of Science degree in Chemistry from Bowling Green State University, completed from 1994 to 1998. His educational background provides a strong foundation for his work in the biopharmaceutical sector.
Career Timeline
Marc Blatchford's career spans multiple roles in the biopharmaceutical industry. He began as an Associate Principal Scientist at Schering-Plough from 2005 to 2009, then transitioned to Novartis Pharmaceuticals as a Principal Scientist until 2012. After a period at Gilead Sciences, he held positions at Achaogen and Ardelyx, culminating in his current role at Erasca, which he has occupied since 2021.